Identifies predictable resistance traits to prevent the reporting of false-susceptible results. Key Organisms Covered in M45
Antimicrobial susceptibility testing (AST) is a cornerstone of modern clinical microbiology. It guides clinicians in selecting targeted, effective therapy for bacterial infections. While common pathogens like Staphylococcus aureus or Escherichia coli have well-established testing protocols detailed in documents like CLSI M100, rare or fastidious organisms present a unique challenge.
CLSI M45 has evolved over time, expanding its scope and incorporating technological advancements.
: CLSI offers certain "Micro Free" resources that may include M45 highlights or summaries for the global community. Clinical & Laboratory Standards Institute | CLSI specific breakpoints for a particular organism mentioned in this document? clsi document m45 pdf
Tables for diverse groups including Abiotrophia , Aerococcus , Campylobacter jejuni/coli , and Listeria monocytogenes Accessing the Standard Labs can access CLSI M45 through various channels:
The 3rd Edition (M45-Ed3) brought several significant updates designed to modernize laboratory practice:
Breakpoints categorized into Susceptible (S), Intermediate (I), Resistant (R), or Susceptible-Dose Dependent (SDD) where applicable. How to Implement CLSI M45 in the Laboratory Clinical & Laboratory Standards Institute | CLSI specific
An occupational pathogen associated with handling fish and livestock. 3. Anaerobic and Environmental Organisms
Utilize the specific QC strains designated in M45 to validate your customized media and testing environments before reporting patient results.
Implementing M45 requires strict adherence to quality management systems. Laboratories should follow these steps when evaluating rare isolates: effective therapy for bacterial infections.
Standard testing concludes at 16–24 hours, but many M45 organisms require 48 hours or longer to demonstrate visible, reliable growth. Structure of the Guideline tables
Clinical microbiology laboratories frequently encounter common pathogens like Staphylococcus aureus or Escherichia coli . However, testing rare, fastidious, or unusual microorganisms presents a unique challenge. This is where the Clinical and Laboratory Standards Institute (CLSI) Document M45 becomes indispensable.
Opportunistic pathogens, often causing bacteremia or eye infections.
Offers guidance on it is clinically relevant to perform susceptibility testing rather than relying on predictable patterns. Critical Limitations